Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation

Prioritization of immunogenic neoantigens is key to enhancing cancer immunotherapy through the development of personalized vaccines, adoptive T cell therapy, and the prediction of response to immune checkpoint inhibition. Neoantigens are tumor-specific proteins that allow the immune system to recogn...

Descripción completa

Detalles Bibliográficos
Autores principales: Borden, Elizabeth S., Buetow, Kenneth H., Wilson, Melissa A., Hastings, Karen Taraszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929516/
https://www.ncbi.nlm.nih.gov/pubmed/35311072
http://dx.doi.org/10.3389/fonc.2022.836821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929516/
https://www.ncbi.nlm.nih.gov/pubmed/35311072
http://dx.doi.org/10.3389/fonc.2022.836821

Ejemplares similares